The value of pharmacological studies in the development of new antinematodal drugs.
D000871:Anthelmintics / Q000494:pharmacology*; D001200:Ascaris / Q000187:drug effects; D001393:Azoles / Q000494:pharmacology; D002800:Cholinesterase Inhibitors; D003486:Cyanides / Q000494:pharmacology; D009467:Neuromuscular Depolarizing Agents; D012500:Santonin / Q000494:pharmacology; D013321:Strongyloides / Q000187:drug effects; D013385:Succinate Dehydrogenase / Q000037:antagonists & inhibitors; D014251:Trichostrongyloidea / Q000187:drug effects; D014258:Trichuris / Q000187:drug effects
D000871:Anthelmintics; D001393:Azoles; D002800:Cholinesterase Inhibitors; D003486:Cyanides; D009467:Neuromuscular Depolarizing Agents; D012500:Santonin; D013385:Succinate Dehydrogenase